• Abstral 100 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	0,1571 mg

  ATC: N02A N02AB N02AB03

• Abstral 200 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	0,3142 mg

  ATC: N02A N02AB N02AB03

• Abstral 300 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	0,47113 mg

  ATC: N02A N02AB N02AB03

• Abstral 400 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	0,6284 mg

  ATC: N02A N02AB N02AB03

• Abstral 600 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	0,9426 mg

  ATC: N02A N02AB N02AB03

• Abstral 800 micrograms sublingual tablets

  Form: tablets, sublingual

  Active substance	Dosage
  FENTANYL CITRATE	1,257 mg

  ATC: N02A N02AB N02AB03

• ActiLogic 700 mg medicated patch

  Form: dressing, medicated adhesive

  Active substance	Dosage
  LIDOCAINE	700 mg

  ATC: N01B N01BB N01BB02

• Adolonta 100 mg/2 ml solution for injection and infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	100 mg

  ATC: N02A N02AX N02AX02

• Adolonta 100 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	100 mg

  ATC: N02A N02AX N02AX02

• Adolonta 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	50 mg

  ATC: N02A N02AX N02AX02

• Adolonta Retard 100 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	100 mg

  ATC: N02A N02AX N02AX02

• Adolonta Retard 150 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	150 mg

  ATC: N02A N02AX N02AX02

• Adolonta Retard 200 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	200 mg

  ATC: N02A N02AX N02AX02

• Adolonta Retard 50 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	50 mg

  ATC: N02A N02AX N02AX02

• Axiago 20 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE	20 mg

  ATC: A02B A02BC A02BC05

• Axiago 40 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE	40 mg

  ATC: A02B A02BC A02BC05

• Nexium 10 mg gastro-resistant granules for oral suspension, sachet

  Form: suspension, oral for preparation from granules

  Active substance	Dosage
  ESOMEPRAZOLE	10 mg

  ATC: A02B A02BC A02BC05

• Nexium 40 mg powder for injection and for infusion solution

  Form: powder for injectable solution and for perfusion

  Active substance	Dosage
  ESOMEPRAZOLE	40 mg

  ATC: A02B A02BC A02BC05

• Nexium MUPS 20 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE	20 mg

  ATC: A02B A02BC A02BC05

• Nexium MUPS 40 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  ESOMEPRAZOLE	40 mg

  ATC: A02B A02BC A02BC05

• Palexia 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	116,48 mg

  ATC: N02A N02AX N02AX06

• Palexia 20 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	23,30 mg

  ATC: N02A N02AX N02AX06

• Palexia 4 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	4,66 mg

  ATC: N02A N02AX N02AX06

• Palexia 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	58,24 mg

  ATC: N02A N02AX N02AX06

• Palexia 75 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	87,36 mg

  ATC: N02A N02AX N02AX06

• Palexia Retard 100 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	116,48 mg

  ATC: N02A N02AX N02AX06

• Palexia Retard 150 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	174,72 mg

  ATC: N02A N02AX N02AX06

• Palexia Retard 200 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	232,96 mg

  ATC: N02A N02AX N02AX06

• Palexia Retard 25 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	29,12 mg

  ATC: N02A N02AX N02AX06

• Palexia Retard 50 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	58,24 mg

  ATC: N02A N02AX N02AX06

• Pazital 37.5 mg/325 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TRAMADOL HYDROCHLORIDE	37,50 mg
  PARACETAMOL	325,00 mg

  ATC: N02A N02AJ N02AJ13

• Pontalsic 37.5 mg/325 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  PARACETAMOL	325 mg
  TRAMADOL HYDROCHLORIDE	37,5 mg

  ATC: N02A N02AJ N02AJ13

• Reandron 1000 mg/4 ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  TESTOSTERONE UNDECANOATE	250 mg

  ATC: G03B G03BA G03BA03

• Rectogesic 4 mg/g rectal ointment

  Form: ointment, rectal

  Active substance	Dosage
  NITROGLYCERIN	4,0 Porcentaje peso/peso

  ATC: C05A C05AE C05AE01

• TransTec 35 micrograms/h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  BUPRENORPHINE	20 mg

  ATC: N02A N02AE N02AE01

• TransTec 52.5 micrograms/h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  BUPRENORPHINE	30 mg

  ATC: N02A N02AE N02AE01

• TransTec 70 micrograms/h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  BUPRENORPHINE	40 mg

  ATC: N02A N02AE N02AE01

• Versatis 700 mg medicated plaster

  Form: dressing, medicated adhesive

  Active substance	Dosage
  LIDOCAINE	700 mg

  ATC: N01B N01BB N01BB02

• Vimovo 500 mg/20 mg modified-release tablets

  Form: tablets, modified release

  Active substance	Dosage
  NAPROXEN	500 mg
  ESOMEPRAZOLE MAGNESIUM	22,3 mg

  ATC: M01A M01AE M01AE52

• Yantil 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	116,48 mg

  ATC: N02A N02AX N02AX06

• Yantil 20 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	23,30 mg

  ATC: N02A N02AX N02AX06

• Yantil 4 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	4,66 mg

  ATC: N02A N02AX N02AX06

• Yantil 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	58,24 mg

  ATC: N02A N02AX N02AX06

• Yantil 75 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	87,36 mg

  ATC: N02A N02AX N02AX06

• Yantil Retard 100 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	116,48 mg

  ATC: N02A N02AX N02AX06

• Yantil Retard 150 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	174,72 mg

  ATC: N02A N02AX N02AX06

• Yantil Retard 200 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	232,96 mg

  ATC: N02A N02AX N02AX06

• Yantil Retard 25 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	29,12 mg

  ATC: N02A N02AX N02AX06

• Yantil Retard 50 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  TAPENTADOL HYDROCHLORIDE	58,24 mg

  ATC: N02A N02AX N02AX06

• Zaldiar 37.5 mg/325 mg effervescent tablets

  Form: tablets, effervescent

  Active substance	Dosage
  PARACETAMOL	325 mg
  TRAMADOL HYDROCHLORIDE	37,5 mg

  ATC: N02A N02AJ N02AJ13